Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-930-1 | CAS number: 68155-00-0 This substance is identified by SDA Substance Name: C14-C18 and C16-C18 unsaturated alkyl alcohol and SDA Reporting Number: 04-060-00.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Assess the acute oral toxicity of the test substance to the rat.
The acute median lethal oral dose (LD50) to rats of the test substance was demonstrated to be greater than 2000 mg/kg body weight.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted to OECD and EC guidelines and in compliance with GLP
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Healthy nulliparous and non-pregnant female RccHan®:WIST albino rats were obtained from a reputable supplier.
The animals were allocated without conscious bias to cages within the treatment groups. They were housed in groups of up to three rats of the same sex.
Each animal was identified uniquely within the study by tail marking. Each cage label was colour-coded and was identified uniquely with the study number, dose level and animal mark.
The animals were allowed to acclimatise to the conditions described below for at least 5 days before treatment. For those animals selected for this study, their body weights were in the range 160 to 177 g and they were approximately eight to nine weeks of age prior to dosing (Day 1).
Animals were housed inside a barriered rodent facility which is designed and operates to minimiseentery of external biological and chemical agents.
Own supply of filtered fresh air, maintains positive pressure withi respects to outside - passed to atmosphere and not re-circulated.
Temperature control range set to; 19 - 23C
Relative humidity control range set to; 40 - 70%
Artificial lighting to give a cycle of 12 hours continuous light and 12 hours continuous dark per 24 hours.
Stand-by electricity supply available should public supply fail.
Alarms activated is there is a failure in any of the condition parameters.
Cages - solid bottomed polycarbonated with stainless steel mesh lid. Autoclaved softwood bark-free fibre bedding in each cage.
Diet - Free access to standard rodent diet, except for overnight prior to and approximately four hours after dosing. contains no added antibiotic, chemotherapeutic or prophylactic agents. Analysed routinely by the supplier for various nutritional components and chemical and microbiological contaminants.
Water - Portable water taken from public supply, freely available via polycarbonated bottles fitted with sipper tubes. Water qualty governed by regulations published by the Department for Environment, Food and Rural Affairs - certificates received routinely from water supplier.
Cages, food hoppers, water bottles and bedding were changed at appropriate intervals.
Environmental enrichment - Aspen chew blocks provided to each cage of animals- provided throughout the study and replaced when necessary, certificate of analysis provided routinely by the supplier. Plastic shelter also provided to each cage of animals - replaced same time as cage.
No other specific contaminants that were likely to have been present in the diet or water were analysed, as none that may have interfered with or prejudiced the outcome of the study was known. - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- Two groups of three fasted female rats received a single oral gavage dose of the test substance, formulated in corn oil, at a dose level of 300 mg/kg body weight. As results at this dose level indicated the acute (median) lethal oral dose of the test substance to be greater than 300 mg/kg body weight, in compliance with the study guidelines a further two groups of three fasted females were similarly dosed at 2000 mg/kg body weight to complete the study.
During the study, clinical condition, body weight and macropathology investigations were undertaken. - Doses:
- 300 mg/kg body weight
2000 mg/kg body weight - No. of animals per sex per dose:
- 3 fasted rats per dose level.
- Control animals:
- no
- Details on study design:
- The appropriate dose volume of the test substance was administered to each rat by oral gavage using a plastic syringe and plastic catheter.
A record of the weight of each formulation dispensed and the amount remaining after dosing was made on Days one and two but was overlooked on Day 3. The balance of these two weights was compared with the predicted usage as a check that the doses had been administered correctly.
Formulations were stirred before and throughout the dosing procedure. - Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- not measured/tested
- Mortality:
- One female (Animal number 10) dosed at 2000 mg/kg died on Day 4. Clinical signs prior to death comprised elevated gait, decreased activity, laboured breathing, dry rales, rapid breathing, piloerection, partially closed eye lids (both eyes), red rimmed eyes (both eyes), lacrimation (both eyes) and hunched posture. These signs were seen from approximately two hour after dosing however the majority of signs were seen from Day 2. A body weight loss of 17g was noted for the decedent between Days 1 and 4. Macroscopic examination of the animal revealed congestion (characterised by darkened tissues/organs) of the kidneys, liver, lungs, spleen and subcutaneous tissue, yellow fluid content in the duodenum, large and small intestine and fluid content in the stomach, atrophy of the cecum and pallor of the heart.
- Clinical signs:
- other: Piloerection was seen in 2 females dosed at 2000 mg/kg (Animal numbers 0011 and 0012) upon return to the cage just after dosing and 2 females (Animal numbers 0008 and 0009) at approximately 30 minutes after dosing. Piloerection was also seen in 2 females
- Gross pathology:
- No abnormalities were noted in any animal at the macroscopic examination at study termination on Day 15.
- Conclusions:
- The acute median lethal oral dose (LD50) to rats of UNJECOL 85AN was demonstrated to be greater than 2000 mg/kg body weight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The above result is based on a limit test and not an actual value
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
The acute toxicity results for the test substance was reviewed with reference to the EU interpretation of CLP, EU Regulation 1272/2008. On the basis that the available tests confirmed the oral LD50 value to be greater than 2000 mg/kg, the test substance is therefore not classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.